Award
NIH Reporter #5P30GM159561-02
COBRE Phase III
Recipient
University of Arkansas for Medical Sciences (UAMS)
Award Amount
$1,147,500.00
Ceiling
$1,147,500.00
Awarded
June 18, 2026
Identifier
5P30GM159561-02
The National Institute of General Medical Sciences awarded the University of Arkansas for Medical Sciences $1,147,500 for COBRE Phase III, supporting research and infrastructure focused on understanding and reducing adverse effects of cancer therapy.
Description
Funding for the Center for Studies of Host Response to Cancer Therapy at the University of Arkansas for Medical Sciences. The center supports multidisciplinary research into cancer therapy side effects, including their mechanisms, early detection, and prevention or treatment.